- call +1-201-465-4211
- email sales@mrinsights.biz
Mumps is a contagious disease typically affecting children and caused by the mumps virus. The characteristic of this disease is the initial onset of headache, loss of appetite, muscle aches, tiredness and fever followed by the typical swelling of one or more salivary glands.
Scope of the Report:
This report studies the Mumps market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Mumps market by product type and applications/end industries.
North America is expected to lead the mumps market, owing to higher rates of vaccination coupled with the expensive cost of vaccination and treatment.
The mumps market in Asia is anticipated to register the third spot after Europe, which is expected to take second largest share in the market during the forecast period.
The global Mumps market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Mumps.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
GlaxoSmithKline
Serum Institute of India
Merck
Sanofi
Tiantan Bio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Preventive Therapies
Curative Therapies
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Institutional Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Mumps Market Overview
1.1 Product Overview and Scope of Mumps
1.2 Classification of Mumps by Types
1.2.1 Global Mumps Revenue Comparison by Types (2017-2023)
1.2.2 Global Mumps Revenue Market Share by Types in 2017
1.2.3 Preventive Therapies
1.2.4 Curative Therapies
1.3 Global Mumps Market by Application
1.3.1 Global Mumps Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Institutional Centers
1.4 Global Mumps Market by Regions
1.4.1 Global Mumps Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Mumps Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Mumps Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mumps Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Mumps Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mumps Status and Prospect (2013-2023)
1.5 Global Market Size of Mumps (2013-2023)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Mumps Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Mumps Revenue, Gross Margin and Market Share (2016-2017)
2.2 Serum Institute of India
2.2.1 Business Overview
2.2.2 Mumps Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Serum Institute of India Mumps Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Mumps Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Mumps Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Mumps Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Mumps Revenue, Gross Margin and Market Share (2016-2017)
2.5 Tiantan Bio
2.5.1 Business Overview
2.5.2 Mumps Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Tiantan Bio Mumps Revenue, Gross Margin and Market Share (2016-2017)
3 Global Mumps Market Competition, by Players
3.1 Global Mumps Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Mumps Players Market Share
3.2.2 Top 10 Mumps Players Market Share
3.3 Market Competition Trend
4 Global Mumps Market Size by Regions
4.1 Global Mumps Revenue and Market Share by Regions
4.2 North America Mumps Revenue and Growth Rate (2013-2018)
4.3 Europe Mumps Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Mumps Revenue and Growth Rate (2013-2018)
4.5 South America Mumps Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Mumps Revenue and Growth Rate (2013-2018)
5 North America Mumps Revenue by Countries
5.1 North America Mumps Revenue by Countries (2013-2018)
5.2 USA Mumps Revenue and Growth Rate (2013-2018)
5.3 Canada Mumps Revenue and Growth Rate (2013-2018)
5.4 Mexico Mumps Revenue and Growth Rate (2013-2018)
6 Europe Mumps Revenue by Countries
6.1 Europe Mumps Revenue by Countries (2013-2018)
6.2 Germany Mumps Revenue and Growth Rate (2013-2018)
6.3 UK Mumps Revenue and Growth Rate (2013-2018)
6.4 France Mumps Revenue and Growth Rate (2013-2018)
6.5 Russia Mumps Revenue and Growth Rate (2013-2018)
6.6 Italy Mumps Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Mumps Revenue by Countries
7.1 Asia-Pacific Mumps Revenue by Countries (2013-2018)
7.2 China Mumps Revenue and Growth Rate (2013-2018)
7.3 Japan Mumps Revenue and Growth Rate (2013-2018)
7.4 Korea Mumps Revenue and Growth Rate (2013-2018)
7.5 India Mumps Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Mumps Revenue and Growth Rate (2013-2018)
8 South America Mumps Revenue by Countries
8.1 South America Mumps Revenue by Countries (2013-2018)
8.2 Brazil Mumps Revenue and Growth Rate (2013-2018)
8.3 Argentina Mumps Revenue and Growth Rate (2013-2018)
8.4 Colombia Mumps Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Mumps by Countries
9.1 Middle East and Africa Mumps Revenue by Countries (2013-2018)
9.2 Saudi Arabia Mumps Revenue and Growth Rate (2013-2018)
9.3 UAE Mumps Revenue and Growth Rate (2013-2018)
9.4 Egypt Mumps Revenue and Growth Rate (2013-2018)
9.5 Nigeria Mumps Revenue and Growth Rate (2013-2018)
9.6 South Africa Mumps Revenue and Growth Rate (2013-2018)
10 Global Mumps Market Segment by Type
10.1 Global Mumps Revenue and Market Share by Type (2013-2018)
10.2 Global Mumps Market Forecast by Type (2018-2023)
10.3 Preventive Therapies Revenue Growth Rate (2013-2023)
10.4 Curative Therapies Revenue Growth Rate (2013-2023)
11 Global Mumps Market Segment by Application
11.1 Global Mumps Revenue Market Share by Application (2013-2018)
11.2 Mumps Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Institutional Centers Revenue Growth (2013-2018)
12 Global Mumps Market Size Forecast (2018-2023)
12.1 Global Mumps Market Size Forecast (2018-2023)
12.2 Global Mumps Market Forecast by Regions (2018-2023)
12.3 North America Mumps Revenue Market Forecast (2018-2023)
12.4 Europe Mumps Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Mumps Revenue Market Forecast (2018-2023)
12.6 South America Mumps Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Mumps Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Mumps Picture
Table Product Specifications of Mumps
Table Global Mumps and Revenue (Million USD) Market Split by Product Type
Figure Global Mumps Revenu
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
